COVID – 19: considerations and strategies for running trials during the pandemic

ARCS Australia


About the Event

Part 10 Trial Participants

With the declaration of COVID-19 as the latest pandemic, organisations are considering all options and developing strategies to ensure continued access to treatment for participants enrolled in trials. Topics to be covered include patient management, protocol compliance, monitoring and drug supply chain.

This webinar is not intended to provide advice. It aims to share what stakeholders are doing to support clinical trial continuity over the next period of time.

ARCS understands this is a quickly changing landscape and is proactively responding to the changes by providing a rolling webinar series on COVID-19. Stay tuned for future virtual events on COVID-19.

MTPConnect are proud to sponsor the series.